Healtheuniverse Inc. (OTC: HLUN), a diversified biotechnology development firm specializing in the development and commercialization of patented biopharmaceutical and biomedical products announced today that it has entered into a Letter Of Intent (LOI) to acquire the assets, operations and clinical database of The California Institute of Cosmetic & Reconstructive Surgery. The acquisition is expected to be accretive to earnings and includes the CICRS clinical database which will prove valuable as the company advances its evidenced based human clinical trials for stem cell applications in the plastic, reconstructive, and cosmetic surgery market. This acquisition is expected to close in the first quarter 2006 subject to customary closing conditions and is another key step to the Company becoming the first to commercialize the use of regenerative medicine and adult stem cells.
